Free Trial

Grifols (GRFS) Stock Forecast & Price Target

$7.00
+0.02 (+0.29%)
(As of 06/21/2024 ET)

Grifols - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$10.50
50.00% Upside
High Forecast$10.50
Average Forecast$10.50
Low Forecast$10.50
TypeCurrent Forecast
6/24/23 to 6/23/24
1 Month Ago
5/25/23 to 5/24/24
3 Months Ago
3/26/23 to 3/25/24
1 Year Ago
6/24/22 to 6/24/23
Consensus Rating
Reduce
Reduce
Reduce
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
4 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$10.50$10.50$10.50N/A
Forecasted Upside50.00% Upside6.82% Upside6.82% UpsideN/A
Get Grifols Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GRFS and its competitors with MarketBeat's FREE daily newsletter.

GRFS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GRFS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Grifols Stock vs. The Competition

TypeGrifolsMedical CompaniesS&P 500
Consensus Rating Score
1.67
2.70
2.50
Consensus RatingReduceModerate BuyModerate Buy
Predicted Upside50.00% Upside900.55% Upside10.92% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Sell
12/5/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$10.00 ➝ $10.50+6.82%
8/29/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight
2/16/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight
2/6/2023AlphaValue
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeBuy
1/18/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
11/25/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral ➝ Neutral
7/15/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy€20.15 ➝ €20.30

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:28 AM ET.

GRFS Forecast - Frequently Asked Questions

What is Grifols's stock forecast and purchase recommendation?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Grifols is $10.50, with a high forecast of $10.50 and a low forecast of $10.50. The consensus rating for Grifols stock is Reduce based on the current 1 sell rating and 2 hold ratings for GRFS. Learn more on GRFS's analyst rating history.

Do Wall Street analysts like Grifols more than its competitors?

Analysts like Grifols less than other "medical" companies. The consensus rating for Grifols is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how GRFS compares to other companies.

Does Grifols's stock price have much upside?

According to analysts, Grifols's stock has a predicted upside of 6.82% based on their 12-month stock forecasts.


Stock Forecasts and Research Tools

This page (NASDAQ:GRFS) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners